Nav

Press Releases

REFLX Labs Partners With Intellectual Ventures to Propel Innovation

REFLX Labs, Inc., creator of Boogio Bionic Foot Sensors™, and the Invention Development Fund at Intellectual Ventures™ (IV®), announce a strategic partnership to pave the way for innovation and commercialization of Boogio wearable technology worldwide. Boogio is a wearable technology that can capture and analyze human activity with high precision and accuracy. By joining forces with IV, REFLX Labs continues to build a strong foundation for innovation and collaboration that connects its technology with partners in numerous industries.

REFLX Labs is a Seattle-based technology firm dedicated to the development and distribution of wearable sensors. The company's flagship product, Boogio Bionic Foot Sensors, is a set of paper-thin sensory stickers and tiny computers that activates any shoe, tracking movement from the ground up to take hands-free control of technology. It is the first wearable device that can sense gravitational forces on the body, inner balance and 3D movement of the feet in real-time. Boogio's sensors are able to detect the pressure exerted in different parts of a person's foot, capturing high-fidelity feedback on movements, including steps, jumps, squats and kicks.

REFLX Labs' will leverage IV resources in three areas. IV will help REFLX source new inventions from the IV global Inventor Network (IVIN) of more than 4,000 active inventors worldwide; IV will offer a license to relevant existing inventions from the IDF portfolio to REFLX; and IV will work as a business development partner for REFLX to find customers for Boogio worldwide.

"We scour the world for ideas that can make a difference. In this case, we didn't have to look any farther than our own backyard," said Chris Alliegro, managing director of the Invention Development Fund at Intellectual Ventures. "The Boogio technology has great potential in fields like gaming and personal fitness, and could also find applications in medicine and robotics among others. We aim to help entrepreneurial companies like REFLX Labs realize that potential by expanding and protecting their innovations, and helping to get their products into the market around the world."

"We know Boogio has major implications across numerous industries. The precision of the system is incredible and because you wear it in your shoe, it is completely transparent in daily life," said Jose Torres, CEO of REFLX Labs. "As a hardware startup, we require guidance and support to build a technology that is scalable and sustainable. Working with the team at IV has been an amazingly positive experience. I've been advised by a team of engineers, business developers and IP strategists to identify challenges and opportunities in this competitive marketplace. We now have the resources and expertise to accelerate partnerships with developers and innovators."

In order to encourage experimentation, innovation, and collaboration, Boogio's platform was designed to be transparent and open allowing developers to easily integrate and build on the technology. For more information about Boogio and to grab a developer kit, please visit www.boogio.com.

About Intellectual Ventures

Founded in 2000, Intellectual Ventures (IV) is the global leader in the business of invention. IV collaborates with leading inventors, partners with pioneering companies and invests both expertise and capital in the process of invention. IV’s mission is to energize and streamline an invention economy that will drive innovation around the world.

About REFLX Labs Inc.

Boogio was pioneered in Seattle in 2013. Using patent-pending technology, REFLX Labs works with the wearable technology developer community to create consumer products for entertainment, health and diagnostics.

For further information, contact:

Lauren Jaeger
Uproar PR for REFLX Labs
ljaeger@uproarpr.com
312-878-4575 x 241

Intellectual Ventures
For press inquiries, please contact press@intven.com. For all other inquiries, please contact info@intven.com or follow IV on Twitter at @IVinvents.

Archives

Twitter | Follow Us »

In 1986, Rita Levi-Montalcini was awarded the Nobel Prize in Physiology or Medicine jointly with colleague Stanley… twitter.com/i/web/status/9…

Dec 14

#DYK 10 million people fall ill from tuberculosis every year worldwide? Our Global Good Fund leveraged @Carbon’s te… twitter.com/i/web/status/9…

Dec 13

At IV, we often draw from varied, even unlikely, backgrounds to build teams. Meet Guillaume Chabot-Couture, whose w… twitter.com/i/web/status/9…

Dec 12